All posts by imreal

CODAC Announces Mobile Medical Unit Able to Dispense Methadone as Part of Full MAT


News Image

“This innovative intervention will help get tools, resources, and supports into communities throughout Rhode Island.” – Rhode Island Governor Dan McKee

CODAC Behavioral Healthcare, the largest non-profit, outpatient provider for opioid treatment in Rhode Island, today announced the launch of its new mobile medical unit that will dispense methadone along with the other two FDA-approved medications for opioid use disorder (OUD) as part of Medication-Assisted Treatment (MAT). CODAC’s mobile medical unit is the first in the nation to be approved under the new DEA regulations that went into effect on July 28, 2021.

CODAC’s 27-foot long mobile medical unit was made possible by a generous grant from the Champlin Foundation; it features a dispensary examination/treatment room, counseling room, waiting area, restroom, and a fully equipped security system. The mobile medical unit will begin providing MAT services, including counseling, and methadone dispensing (as well as treatment with buprenorphine and naltrexone) to patients residing in Woonsocket. Services will be provided on-site Monday through Saturday from 6:30 to 10 a.m., with the presence of a medical doctor on alternating days of the week. Counseling services will be facilitated via Telehealth in an effort to provide more hands-on support. Other on-site services will include but not be limited to blood pressure screening, glucose readings, and mental health screening.

“Access to care is more important than ever amid our soaring overdose rates,” stated Linda Hurley, President/CEO of CODAC. “This mobile medical unit will allow us to face that challenge, both geographically and demographically. It will allow us to bring treatment to individuals struggling with addiction and literally meet them where they are – in the places where that treatment is most needed.”    

In Rhode Island, deaths from accidental drug overdose (OD) in 2021 were higher than for any other year on record, according to the state Department of Health, and recently passed the benchmark of 100,000 deaths nationally in a twelve-month reporting period.

Rhode Island Governor Dan McKee stated: “A key element of our response to the opioid overdose crisis is meeting people where they are. This new mobile medical unit from CODAC Behavioral Health does just that,” said Governor Dan McKee. “This innovative intervention will help get tools, resources, and supports into communities throughout Rhode Island, and will allow public health workers to respond to trends in overdose activity. Recovery and hope are never out of reach.”

K. Joseph Shekarchi, Speaker of the Rhode Island House of Representatives stated: “CODAC again brings Rhode Island to the forefront of the efforts to address the opioid overdose epidemic. The mobile medical unit will bring services to communities who have the most difficulty receiving those services and have the most need. Thank you again, CODAC.”

Dominick J. Ruggerio, President of the Rhode Island Senate stated: “We are extremely proud of the work that CODAC has done, again being the first in the nation to provide newly DEA regulated mobile medical unit services to address the opioid epidemic. This is a big step in keeping our friends and family safer from this disease.”

Mark W. Parrino, M.P.A., President, American Association for the Treatment of Opioid Dependence, stated: “I am grateful to Linda Hurley and her CODAC colleagues for being among the first to launch a new mobile van under the DEA regulations, which will extend the reach of CODAC’s Opioid Treatment Programs into underserved areas of Rhode Island. It represents the opportunity to expand the OTP hub sites to reach underserved people in desperate need of care for their opioid use disorder.”

Ben Lessing, MSW, CEO, Community Care Alliance, stated: “We have lost too many people in Woonsocket due to opioid addiction and overdose deaths. Community Care Alliance is pleased to welcome CODAC as an additional partner to address this acute behavioral healthcare need. Access, rapid response and addressing opioid concerns in a comprehensive manner is critical. We believe that the presence of CODAC’s Mobile Medical Unit will help to improve current conditions on the ground.”

About CODAC Behavioral Healthcare

CODAC Behavioral Healthcare, a non-profit organization founded in 1971, is Rhode Island’s oldest and largest provider of outpatient services for opioid use disorder, other substance use disorders, and concurrent behavioral health challenges. With eight locations across Rhode Island, CODAC has attained Center of Excellence designations for each of its treatment sites. CODAC has done extensive work with individuals involved in the criminal justice system since 1994 and, in 2016, launched a program with the Rhode Island Department of Corrections (RIDOC) that was the first of its kind in the United States to screen all inmates for opioid use disorder and provide medication-assisted treatment (MAT) for those in need. Results from CODAC’s RIDOC program have been studied and published, and the program has been recognized as “a model for all 50 states” by the Department of Justice, SAMHSA and multiple other national agencies. In addition, CODAC is now licensed in Massachusetts to operate an Opioid Treatment Program (OTP). For more information about CODAC, visit: http://www.codacinc.org.

Share article on social media or email:

Interspinous Device Controversies in Understanding Patient Selection: Inspan vs Coflex


L5-S1 Inspan Interspinous Interlaminar Thoracolumbar Fixation for Fusion and Spinal Stenosis compared to Coflex

“Inspan treats the facet and disc pain in all motions because it stabilizes the segment. Therefore, if you have a patient with facet pain, disc pain and spinal stenosis, Inspan treats all three conditions” says Professor Dr. Kingsley R Chin.

An Interview with Board-Certified Harvard Trained Orthopedic Spine Surgeon and Inventor, Professor Dr. Kingsley R Chin


  • HOW DOES INSPAN COMPARE TO COFLEX?


“I’m going to answer that not so much as a competitive comparison but based on treatment, diagnosis, and patient selection.”

Let’s start with patient selection and diagnosis. If the patient has spinal stenosis as the primary pathology and if you are going to perform a midline decompression and place an interspinous device under CPT code 22867, then both Coflex and Inspan could be used as devices for that treatment. The difference is that if you use Coflex, that device is acting as an extension block. When you go into flexion, or bend laterally or rotate, it’s not secure so it is going to have movement and stresses on the spinous processes and that is one of the drawbacks of dynamic extension blocks. Many of these devices, most notably X-Stop, Vertiflex Superion and Coflex, you will see spinous process erosions, spinous process fractures and implant dislocations that can be reviewed on the FDA MAUDE Database for incidences of reported device failures. You will see plenty of examples here but note that there may be several other cases beyond the ones reported.

  • PATIENT SELECTION AND BENEFITS FOR SPINAL STENOSIS?


The Inspan device increases the disc and foraminal heights, fixates and stabilizes the spinous processes and the laminas and therefore the facets. This means that the device treats spinal stenosis but also has a stabilizing impact on the segment in all motions whether in flexion, extension, lateral bending and rotation. This can be beneficial in a patient who is osteoporotic to avoid spinous process fractures, erosions and dislocations of the device. None of these have been reported with Inspan. The other patient selection criteria is facet-related back pain or discogenic mediated back pain. These patients if treated with Coflex or any extension block device, will not get the benefit of pain relief from disc or facets because you are maintaining the same amount of motion as before especially in flexion that is causing the pain. You may get some dampening on the facets in extension if they’re having some amount of back pain on extension. Inspan treats the facet and disc pain in all motions because it stabilizes the segment. Therefore, if you have a patient with facet pain, disc pain and spinal stenosis, Inspan treats all three conditions while Coflex will just be treating spinal stenosis in extension.

  • PATIENT SELECTION AND BENEFITS FOR FUSION?


Next is fusion, if you have a patient with grade 1 or grade 2 spondylolisthesis, severe facet degeneration, disc degeneration and spinal stenosis you can chose to fuse this patient with an interspinous fixation device instead of pedicle screws and interbody cages. You could consider using the Coflex device since they also have a fusion device in which you place a pin between the spinous processes to hold the device in place and the reason for that pin clearly is to avoid the patient having motion in flexion and other planes. Inspan also works well here because the device can achieve rigid fixation of the facets and the spinous processes, and it is a very powerful device for that. If you look at the Inspan footplates they are symmetrical, with very sharp and strong teeth configuration, also long enough such that when the two plates come together, they are fixating almost across the spinous processes. Inspan has been a proven solution for fusion with bone graft and so both devices could be used in these fusion cases instead of traditional pedicle screws but Inspan is a more rigid device than Coflex.

  • INDICATION FOR USE AND FDA APPROVAL?


Inspan is the first interspinous process device to be FDA cleared for both spinal stenosis and fusion from T1 to S1. Coflex is indicated for spinal stenosis from L1 to L5.

INSPAN

Indications For Use

The Inspan ScrewLES Fusion System is a posterior non-pedicle supplemental fixation system intended for use in the noncervical spine (T1-S1). It is intended for plate fixation/attachment to the spinous process for the purpose of achieving supplemental fusion for the following indications: spondylolisthesis, trauma (fracture or dislocation), tumor, degenerative disc disease (defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies), or lumbar spinal stenosis. The device is intended for use with bone graft material and is not intended for stand-alone use.

https://www.accessdata.fda.gov/cdrh_docs/pdf21/K213266.pdf

COFLEX

Approval Order Statement

Approval for the Coflex interlaminar technology. This device is indicated for use in one- or two-level lumbar stenosis from l1- l5 in skeletally mature patients with at least moderate impairment in function, who experience relief in flexion from their symptoms of leg/buttocks/ groin pain, with or without back pain, and who have undergone at least 6 month of non-operative treatment. The Coflex is intended to be implanted midline between adjacent lamina of 1 or 2 contiguous lumbar motion segments. Interlaminar stabilization is performed after decompression of stenosis at the affected level(s).

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P110008

  • PATIENT SELECTION SUMMARY – INSPAN VS COFLEX?


If you are trying to decide between Coflex and Inspan you should be looking at the two different operations – patients with stenosis and patients who require fusion. Patients with spinal stenosis and pain from the facets or discs should be considered for Inspan to treat the facet pain and the disc pain. If you have concerns about osteoporosis, spinous process fractures or erosions, go with Inspan. If you diagnose facet tropism where the facets are not symmetric on both sides, according to Dr. Scott Boden’s paper, those patients are going to have degeneration of the facets and may also lead to some spondylolisthesis. These patients require a posterolateral fusion, you can consider using Inspan or Coflex plus a biologic such as Nanofuse Biologics (synthetic bioactive glass plus demineralized bone matrix). If you are trying to have the strongest fixation of the facets, Inspan will be the winning choice.

The authors views are a perspective only, and not to be held responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this article is provided “as is” and intended to be used for educational and informational purposes only. Past performance does not guarantee future results and none of the statements in this article are meant to provide any financial, investment, tax, or legal advice that should be independently verified.

About INSPAN, LLC

INSPAN, LLC is privately owned by the KICVentures Group and is focused on advancing the platform of patented interspinous interlaminar fixation technology. The Inspan device has a proven ten-year track record with thousands implanted since FDA clearance in 2010. There are no documented device-related failures or spinous process fractures that have plagued other competitive ISP devices. Click here to review Inspan’s FDA clearance and indications for use

https://myinspan.com/

About KICVentures Group

Our founders have been investing in spine surgery since 2000, which makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble long-term decisions with leading physicians to advance clinical outcomes, such as when we acquired AxioMed Viscoelastic Disc Technologies, while the leading spine companies look the other way to invest in advancing spinal fusion.

https://www.kicventuresgroup.com/

AUTHORS

Aditya Humad is the Co-Founder & CFO of the KICVentures Group, and previously on Wall Street as an investment banker at JPMorgan Healthcare M&A. He studied Bioengineering at the University of Pennsylvania and Finance at the Wharton School of Business.

Dr. Kingsley R. Chin MBA is a board-certified Professor of Orthopedic Spine Surgery and honors graduate of Harvard Medical School and the Harvard Combined Orthopedic Residency Program. He did his spine fellowship with Dr. Henry H Bohlman. He was Chief of Spine Surgery at the University of Pennsylvania.

Dr. Jason A. Seale MBA is a medical doctor and entrepreneur. He is the clinical director at the LES Clinic.

Share article on social media or email:

Three Olansky Dermatology & Aesthetics physicians receive Top Doctors honors in Atlanta magazine


Dr. Jodi Ganz, managing partner of Olansky Dermatology & Aesthetics.

“At Olansky Dermatology & Aesthetics, we’re fortunate to have many of the top dermatologists in the state,” says Dr. Jodi Ganz. “Our practice is dedicated to providing the utmost expertise and compassion to each of our patients.”

Three physicians from Olansky Dermatology and Aesthetics – Georgia’s top-rated dermatology practice – rank among metro Atlanta’s Top Doctors in Atlanta magazine’s July Issue. Those physicians are: Dr. Sonya Bellamy, Dr. Jodi Ganz, and Dr. Humza Ilyas.

Dr. Jodi Ganz, managing partner of Olansky Dermatology & Aesthetics, says the recognition reflects the practice’s goal of offering optimal care and creating an elite team of dermatologists.

“I am honored and grateful to be among the doctors who have been recognized,” says Dr. Ganz. “We greatly value our doctors’ commitment to providing excellent patient care. At Olansky Dermatology & Aesthetics, we’re fortunate to have many of the top dermatologists in the state. Our practice is dedicated to providing the utmost expertise and compassion to each of our patients.”

Atlanta magazine creates its list from a roster of doctors selected by Professional Research Service (PRS). A total of 1,098 physicians appear on the publication’s 2022 list. These doctors represent the following counties in Georgia: Carroll, Cherokee, Clayton, Cobb, Coweta, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Hall, Henry, and Rockdale. PRS creates its list by conducting an online peer-review survey of physicians in the metro Atlanta area. Physicians are asked to nominate fellow physicians they deem the best in their field of practice. Many votes were cast honoring excellence in all fields of medicine. The featured doctors were screened and selected through the verification of licensing and review of any infractions through applicable boards, agencies, and rating services.

Drs. Bellamy, Ganz and Ilyas are now accepting telehealth appointments and seeing patients at Buckhead and Roswell locations of Olansky Dermatology & Aesthetics. To schedule a visit, call: 404-355-5484. Learn more at OlanskyDermatology.com.

Dr. Sonya Bellamy is a board-certified dermatologist. She is a member of the American academy of Dermatology and the Atlanta Association of Dermatology and Dermatologic Surgery. She earned a Bachelor of Science degree and a medical degree from the University of Illinois. Dr. Bellamy has been in private practice in the Atlanta area since 1992. Her professional interests include general, surgical, and cosmetic dermatology. She accepts telehealth appointments, and she sees patients at the Buckhead and Roswell locations.

Dr. Jodi Ganz is a board-certified dermatologist, a fellow of the American Academy of Dermatology, and managing partner of Olansky Dermatology & Aesthetics. Dr. Ganz practices general dermatology and some aesthetic services. Additionally, she specializes in female genital dermatology. Dr. Ganz performs a variety of procedures that help patients to enjoy the improved lifestyle that comes with healthy, beautiful skin. She accepts telehealth appointments, and she sees patients at the Buckhead and Roswell locations.

Dr. Humza Ilyas is a board-certified dermatologist and Mohs surgeon. He is a member of the American Board of Dermatology, the American Academy of Dermatology, and the American College of Mohs Surgery. Dr. Ilyas specializes in Mohs surgery and advanced reconstructive techniques. He has published widely, presented at medical conferences, and written textbook chapters on non-melanoma skin cancer for primary care physicians. He accepts telehealth appointments, and he sees patients at the Buckhead and Roswell locations.

Olansky Dermatology & Aesthetics is your dermatology solution. Our ability to provide full-service dermatology to patients of all ages is a distinct benefit to choosing our practice. We offer medical, surgical, cosmetic, and aesthetic services to our patients, and even same-day appointments when possible. This makes us not only a convenient solution for your family but a comprehensive one as well. With services ranging from our in-house Mohs surgery for skin cancer, advanced laser therapy for psoriasis or our aesthetic services for skin rejuvenation, Olansky Dermatology & Aesthetics can handle all of your skin concerns. For more details, visit our website at OlanskyDermatology.com or call 404-355-5484.

Interviews are available upon request.

Share article on social media or email:

MassageLuXe Opens First Location in Myrtle Beach, South Carolina


News Image

“People are turning away from using artificial means like pain medications to combat aches and pain. Being able to offer massage therapy as part of a healthy self-care plan is important to us.” – Robin Coble, MassageLuXe Franchise Owner

Patrick Coble has spent more than 25 years as an electrical contractor. But it wasn’t until he got a massage that the proverbial light bulb went on — indicating he was ready for a new business opportunity with MassageLuXe.

Coble and his wife Robin are the owners of the newest MassageLuXe franchise set to open in August in The Village Shops at 7937 North Kings Hwy in Myrtle Beach’s Grande Dunes community. It’s the first South Carolina location for the brand as it expands into the Palmetto State.

“I was also looking to switch things up in my career. Working 12 to 14 hours a day, not to mention the odd positions I’ve twisted my body in throughout the years, takes a toll. For our 20th wedding anniversary, Robin gave me a gift certificate to get a massage. It was the first time I ever really had a massage, and I absolutely loved it,” says Patrick Coble. “I started getting massages on a regular basis and was impressed with the positive impact it had on my aches and pains.”

When they had trouble booking appointments as customers at existing day spas in Myrtle Beach, they knew MassageLuXe was a great business opportunity and something the community needed.

“The massage industry is changing. A massage is no longer considered an indulgence. It is an affordable and essential part of one’s health, wellness, and self-care,” says Robin Coble, who has a background in skincare and cosmetology. “People are turning away from using artificial means like pain medications to combat aches and pain. Being able to offer massage therapy as part of a healthy self-care plan is important to us.”

Benefits of Massage Therapy:

The mission of MassageLuXe is to deliver the highest quality massage, facial, and waxing services in an environment that is both luxurious and relaxing to all guests.

The Cobles say they look forward to serving the needs of many different groups of people, including two of the largest communities in the Myrtle Beach area.

Seniors – Just over 23% of the Myrtle Beach community is people aged 65 and up. Regular massage offers many benefits to the entire body and helps seniors experience an improved quality of life, increased energy levels, and reduction of aches and pains.

Golfers – There are approximately 3.2 million rounds of golf played annually in the Myrtle Beach area. Regular massage loosens and stretches stiff joints and muscles, which can increase one’s range of motion and flexibility, possibly improving their golf swing.

MassageLuXe of Myrtle Beach is currently offering a special presale offer on the spa’s website for a one-hour massage or LuXe facial for just $39. Customers who sign up for a MassageLuXe monthly membership before the grand opening will receive a discounted rate of $65.

Expansion Plans:

In addition to the location at The Village Shops, the Cobles have plans to expand and open at least five MassageLuXe day spas in South Carolina.

“We looked at several different brands until we found MassageLuXe. We were drawn in by the design and layout of the spas and then sold on the business plan,” adds Patrick Coble. “Even though I have business ownership experience, I will no longer be on my own. I am excited to be working with a team of people guiding me and supporting me who are invested in my success.”

MassageLuXe franchisees are beneficiaries of unmatched support and training from expert industry professionals who help ensure success in target markets. Spa owners also have access to top-of-the-line management software to help coordinate each part of their business.

“We are thrilled to welcome Patrick and Robin Coble to the MassageLuXe franchise family,” says Mark Otter, president and CEO of MassageLuXe. “As we continue to grow, it is more important than ever that we partner with owners who are passionate about our brand and the health and wellness of our customers. We are also excited to introduce MassageLuXe to the great people of Myrtle Beach.”

MassageLuXe is on schedule to open more than 20 new locations this year and could reach as many as 250 new locations over the next four years.

To learn more about MassageLuXe, visit https://massageluxe.com/.

For more information about MassageLuXe franchising, visit https://franchise.massageluxe.com/.

###

About MassageLuXe

Founded in 2008 in St. Louis, Missouri, MassageLuXe is a fast-growing franchise-based spa company with a mission to provide an unparalleled experience that supports and encourages health, well-being, and quality of life. MassageLuXe delivers the highest quality massage, facial, and waxing services in a comfortable, relaxing, and luxurious environment.

Massage is a service that improves health, promotes relaxation and overall well-being for the consumer, and has been practiced throughout the world for thousands of years. MassageLuXe currently has more than 70 locations across 16 states and is planning to expand to 250 locations in the next four years.

Share article on social media or email:

Cornerstone AI Raises $5 Million Seed to Solve Healthcare’s Data Problem


News Image

“Cornerstone ensures that healthcare is not compromised because of bad data, while freeing up data scientists and researchers to do the work that matters.”

Today, Cornerstone AI, a new company solving healthcare’s data challenges to improve research and care, publicly launched its first-of-its-kind AI platform. Cornerstone is developing highly intelligent, automated software to accurately and efficiently clean and prepare data in a fraction of the time of traditional methods. Its software can significantly accelerate data analysis and healthcare research. Cornerstone’s founders incubated the company in partnership with Initiate Studios, a new venture studio that co-creates companies at the intersection of healthcare, life sciences and technology.

The company also announced a $5 million seed round led by Healthy Ventures. The raise marked the first investment for Initiate’s affiliated fund, Initiate Ventures. Healthy Ventures General Partner Anya Schiess and Initiate’s Rowan Chapman and lana Dimkova have joined Cornerstone’s board of directors. Funds will be used to further product development and scale the business to meet demand.

Cornerstone debuts at a time when data powers much of the innovation in the healthcare space. For the data to be meaningful and yield insights that impact lives, it must be accurate, connected, standardized and trusted. This is difficult to achieve given the exponential rise in volume and complexity compounded by the manual processes currently in place to prepare data for analysis.

“AI/ML is revolutionizing the healthcare industry,” said Schiess. “But in order for an AI system to work, datasets must be complete, and they must be accurate. Cornerstone is taking a novel approach that uses AI to make the data itself better, which translates to better AI systems and ultimately better healthcare.”

Currently, 300 petabytes of healthcare data are generated each day. Unfortunately the manually created rules tasked with cleaning this data are not up to the challenge. As a result, data scientists typically spend 80% of their time on data cleaning, rather than on analysis and discovery itself, costing billions annually. The most advanced teams spend precious time developing internal tools to tackle aspects of this issue, but rarely have the staff, focus or time to create a comprehensive solution.

“Data quality has become one of the biggest problems in the healthcare industry – one that has significant consequences,” said Cornerstone Co-founder and CEO Michael Elashoff. “Poor quality data leads to drug development being delayed, patients being misdiagnosed and inaccurate scientific conclusions. Cornerstone was created to efficiently solve these problems at a time when resources are precious. In doing so, Cornerstone ensures that healthcare is not compromised because of bad data, while freeing up data scientists and researchers to do the work that matters.”

Bringing Accuracy, Intelligence and Speed to Data Preparation

Cornerstone provides a first-of-its-kind software to improve the speed and precision of data preparation. It automatically structures and corrects data, allowing teams to use more patients, more data points and arrive at more precise analyses. The novel self-learning AI methods are backed by a regulatory grade audit trail.

Cornerstone is already working with companies across multiple medical areas, data sources and volumes. According to feedback, customers have achieved outstanding results. A medical device company used to spend six months manually cleaning each new dataset; with Cornerstone that time was reduced to just nine days – a 20x time savings. Similar results have been seen on medical record data, clinical trial/registry data, and digital health data.

Built on Experience

Cornerstone was created by Elashoff, who has more than 20 years experience in machine learning and biostatistics, including time spent as an FDA statistical reviewer and team leader, and Andrew Howland, who was previously the director of data science at Medidata Solutions. The pair met at Medidata, after the company acquired Patient Profiles, a startup Elashoff had founded to develop machine learning and AI methods for clinical trials. Through their respective experiences, Elashoff and Howland understood the dirty data problem firsthand.

They came up with a highly advanced solution to the problem and connected with former colleague Rowan Chapman who had recently founded a venture of her own – Initiate Studios. Chapman, along with Initiate’s co-founders Dimkova and Jessica Owens, invited Cornerstone to become the first company incubated in Initiate Studios.

“If you talk to any analyst or data scientist in healthcare today, they will tell you that the rote process of cleaning data keeps them from important work. It is an enormous source of frustration and cost, and it can leave organizations working relatively blindly if not performed well,” said Chapman. “Mike, Andrew, and our whole Cornerstone team is devoted to changing this process to free up people to do what they’ve trained to do – to make scientific breakthroughs that will impact lives.”

About Cornerstone AI

Founded by healthtech veterans, Cornerstone AI unlocks the power of clinical data through advanced software that quickly and accurately prepares data for analysis. Cornerstone’s solution learns the structure and relationships for any dataset, creates models for every data point leveraging what was learned, uses the models to identify corrections for inconsistent data points,and intelligently fills in missing data and exports clean data with a complete audit trail. Learn more at http://www.cornerstoneai.com.

About Healthy VC

Healthy Ventures is an early stage health care technology fund that was founded to invest in founders solving problems at the intersection of health care and technology. The team combines a firm understanding of the idiosyncratic health care vertical with a horizontal playbook of what has worked before, and better, in other industries. Learn more at http://www.healthy.vc.

About Initiate

INITIATE is a company creation and investing platform that partners with exceptional entrepreneurs to create tomorrow’s breakthroughs and reshape the future of healthcare. INITIATE focuses on the intersection of healthcare, life sciences, and technology, including healthtech SaaS, diagnostics, life sciences tools, and biopharma platforms & services. Learn more about company creation at http://www.initiate.studio and early stage venture investing at http://www.initiate.vc.

Share article on social media or email:

SpIntellx and Inspirata Announce New Technical Partnership and Integration to Expand Access to Next Generation Explainable AI Software for Breast Biopsies


SpIntellx and Inspirata Announce New Technical Partnership

This strategic collaboration over the next few years will bring the teams of SpIntellx and Inspirata together in building tools to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows.

SpIntellx, Inc., and Inspirata have announced that they will collaborate to integrate the SpIntellx HistoMapr-Breast™ platform and Inspirata’s Dynamyx® software into one seamless solution. HistoMapr-Breast is the one and only computational pathology software that taps the power of explainable artificial intelligence (xAI) for healthcare providers to diagnose, prognosticate and treat breast cancer more efficiently and accurately. Dynamyx has the distinction of holding the very first FDA clearance for digital pathology software with multiple scanners, enabling pathologists to use whole slide images (WSIs) for primary diagnosis in place of traditional glass slides, yielding an array of powerful benefits to pathologists and laboratories.

In addition, SpIntellx brings a proprietary spatial analytics approach to digital pathology. The advanced spatial analytics capture the architecture and communication patterns of the various histological structures, thus yielding maximally predictive information from patients’ tissue sections to inform therapeutic strategies and clinical decisions. The revolutionary HistoMapr™, xAI powered precision pathology software platform provides actionable solutions to transmitted light applications. HistoMapr brings efficiency and accuracy gains and maximizes information and knowledge for increasingly complex datasets. HistoMapr-Breast is applied to breast core biopsies to differentiate and rank a broad spectrum of breast pathologies from benign to atypia to ductal carcinoma in situ (DCIS) to invasive/malignant with high accuracy.

HistoMapr-Breast uses spatial information to provide clear and unbiased justifications for its automated recommendations. As a result, pathologists and other software users can ask “why?” and HistoMapr-Breast can answer this basic question, using data and pathologist-friendly language to explain its decisions.

“We are excited to partner with SpIntellx to bring new translational research and clinical spatial analysis tools to the Dynamyx digital pathology platform,” said Mark Lloyd, Founder and Executive Vice President of Inspirata. “The spatial and functional relationships between cells is central to precision pathology. Building translational research tools into the Dynamyx workflow helps to facilitate the adoption of digital pathology.”

HistoMapr-Breast is the first of many planned spatial analytics and xAI pathologist guides designed to: triage the case workload to direct the most difficult and borderline cases to subspecialists; perform active quality assurance to improve pathologists’ accuracy and efficiency and reduce intra- and inter-pathologist discordance; provide transparent xAI guidance that explains why the algorithms made a specific recommendation; and facilitate standardized reporting in real time. The HistoMapr technology and approach is generalizable to a wide range of diseases, both tumor and non-tumor in nature. The platform is also the first in the SpIntellx’s larger efforts to harness the power of xAI-assisted lab processes in the development of diagnostics, prognostics, therapeutic strategies, and drug development for tumor and non-tumor diseases.

“Explainable AI is a vital feature in building trust and transparency between pathology disease experts and computational pathology systems, and it is also a departure from more traditional black-box AI approaches to digital pathology such as deep learning,” stated SpIntellx Co-founder, President and CTO, S. Chakra Chennubhotla, PhD. “As machine learning accelerates in medicine, improved communication between humans and their machine learning tools is critical.”

SpIntellx and Inspirata customers will benefit from the seamless integration of HistoMapr-Breast™ and Dynamyx digital pathology platform for more efficient breast core-biopsy workflow with access to unbiased and advanced spatial analytics powered by xAI.

“This strategic collaboration over the next few years will bring the teams of SpIntellx and Inspirata together in building tools to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows,” added SpIntellx CEO, B. Dusty Majumdar, PhD.

About SpIntellx:

SpIntellx, Inc., is the precision pathology company based in Pittsburgh, PA that applies its proprietary unbiased spatial analytics and explainable AI to transform computational and systems pathology to precision pathology and guide clinicians and researchers with powerful tools so they can See More, Know More, and Power Precision Pathology. For more information on SpIntellx, please visit: http://www.spintellx.com

About Inspirata

Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally. To learn more, visit http://www.inspirata.com.

Contact: info@spintellx.com

SpIntellx, Inc.

100 S. Jackson Avenue,

Pittsburgh, PA 15202

https://www.spintellx.com

https://www.linkedin.com/company/spintellx/

https://twitter.com/spintellx

Share article on social media or email:



EDPMA Concerned About Systemic Denial and Delay In Payment by Payers Affecting the Delivery of Emergency Care


News Image

We strongly believe that emergency physicians should be fairly reimbursed for the delivery of emergency care, and payers should do their part to not undermine the emergency medical health care delivery system or the overall health of our healthcare system.

The Emergency Department Practice Management Association (EDPMA) is concerned that payers are denying payments to emergency medicine physicians for essential and lifesaving care they provide to patients.

EDPMA believes that emergency physicians should be able to deliver high-quality, cost effective care in the emergency department and that payers should reimburse highly-trained emergency physicians based on a patient’s presenting symptoms.

However, many payers prioritize profits over patient care with the systemic practice to unnecessarily delay, deny, or reduce payments. EDPMA believes this is wrong and advocates on the regulatory, federal, and state levels to combat this practice on behalf of its members.

EDPMA also supports the efforts of our member organizations to advocate on behalf of their emergency physicians, such as Fremont Emergency Services’ litigation to hold UnitedHealthcare accountable for its policy to withhold payment to ER doctors after services have been rendered. In this vein, we support our colleague’s efforts to advocate for emergency physicians and patients by any means necessary, including litigation.

“EDPMA continues to hold payers accountable for systemic practices that do not acknowledge or compensate for medical decision making in the emergency department,” says Don Powell, DO, FACEP, EDPMA Chair of the Board. “We strongly believe that emergency physicians should be fairly reimbursed for the delivery of emergency care, and payers should do their part to not undermine the emergency medical health care delivery system or the overall health of our healthcare system. EDPMA is in the business of emergency medicine and will continue to advocate for its members and patients.”

About EDPMA

The Emergency Department Practice Management Association (EDPMA) is the nation’s largest professional physician trade association focused on the delivery of high-quality, cost-effective care in the emergency department. EDPMA’s membership includes emergency medicine physician groups of all sizes, as well as billing, coding, and other professional support organizations that assist healthcare providers in our nation’s emergency departments. Together, EDPMA’s members deliver (or directly support) health care for about half of the 146 million patients that visit U.S. emergency departments each year. Visit http://www.edpma.org.

Share article on social media or email:

Validation Institute Partners with The Association for Behavioral Health and Wellness (ABHW) for the 2022 Behavioral Health & Well-Being Congress, Sept 28-30 in VA


News Image

Behavioral Health & Well-Being Congress

“The Behavioral Health & Well-Being Congress aligns with the Validation Institute’s mission of providing relevant and hyper-timely content, opportunities, and resources to healthcare stakeholders,” stated Vice President of Strategy and Content, Haritha Krishnarathnam.

Validation Institute announced a partnership this week with The Association for Behavioral Health and Wellness (ABHW) to host the Behavioral Health & Well-Being Congress, September 28-30, 2022, at The Westin Alexandria Old Town in Alexandria, VA. The Congress will focus on the new era of behavioral health and wellness opportunities: driving new paradigms in access, delivery, and support. Learn more at https://behavioralhealthcongress.com.

As part of the partnership, ABHW will organize the Policy Summit that will take place on the first day of the Congress, September 28.

The past two years have ignited new challenges and unleashed new opportunities in accelerating the access, delivery, and quality of behavioral health solutions. Promoting behavioral and mental healthcare options and prevention are more critical than ever. This year’s event will spotlight how the collaborative contributions of health systems, health plans, clinicians, treatment providers, employers, advocates, and policymakers are moving the needle in creating affordable, accessible services and treatment for behavioral health-related challenges.

“Improving our behavioral health system and increasing access to mental health and substance use disorder treatment are at the forefront of the mind of the President of the United States, his Cabinet, Members of Congress, and state legislators. The Policy Summit will provide a venue to hold thought-provoking conversations on how legislation and regulation can help us address issues such as the workforce shortage, suicide prevention, and the opioid crisis, and develop strategies on how to combat these issues,” said Pamela Greenberg, President and CEO, ABHW. “The Summit and the overall Congress will be the perfect place to immerse yourself in behavioral health policy and other critical issues.”

“The Behavioral Health & Well-Being Congress aligns with the Validation Institute’s mission of providing relevant and hyper-timely content, opportunities, and resources to healthcare stakeholders,” stated Vice President of Strategy and Content, Haritha Krishnarathnam.

“Our partnership with ABHW and incorporating the Policy Summit into the Congress will further enhance our mission by delving into the recent and impending legislative decisions that will have a major and immediate impact in the access, delivery, and quality of behavioral and mental health services,” continued Krishnarathnam.

The Behavioral Health & Well-Being Congress includes strategic keynotes, breakout sessions, and programming across 2+ days and 60+ speakers focused on how stakeholders are advancing strategies in addressing the following and more:


  • The emerging behavioral health crisis in adolescent and young adult populations
  • The rising rates of those afflicted with mental illness and substance use disorders
  • The critical shortage of the behavioral health workforce
  • The mounting challenges resulting from the pandemic of the widening gap in delivering the equitable access, quality, and affordability of behavioral health and wellness services and programs

About Validation Institute:

Validation Institute is dedicated to providing unbiased, data-driven insights on health care solutions and services by validating performance claims made by solutions providers and educating purchasers to drive transparency in the marketplace and maximize cost-savings.

https://validationinstitute.com/

About Association for Behavioral Health and Wellness:

The Association for Behavioral Health and Wellness (ABHW) is the leading association working to advance federal policy and mental health and addiction services.

https://abhw.org/

Press Contact:

Reena Joseph

Director, Marketing & Partnerships

Validation Institute

781-939-2446

reena.joseph@validationinstitute.com

Share article on social media or email:

University of La Verne Expands Online Program Offerings to Include Master’s Degrees in Teaching, Health Administration, and Public Administration


The University of La Verne now offers more than a dozen undergraduate and graduate programs fully online.

The University of La Verne is offering three additional master’s degree programs fully online starting this fall. These include the Master of Arts in Teaching, Master of Health Administration, and Master of Public Administration.

The university has long offered all three programs via in-person or hybrid formats. The new online options will be offered in addition to those options, providing students with flexible and convenient pathways to pursue degrees in these high-demand fields.

The Master of Arts in Teaching program in the LaFetra College of Education prepares students to shape the future of California’s youths, families, and communities by becoming an influential elementary, middle, or high school teacher. The program is approved by the California Commission on Teacher Credentialing and emphasizes language development, cultural diversity, and humanistic approaches to the learning process.

The new online format will allow students to pursue four credential tracks, which include: Multiple Subject Teaching Credential; Single Subject Teaching Credential; Mild/Moderate Education Specialist Preliminary Credential; and a Dual Credential option, which allows graduates even greater flexibility to complete both the Mild/Moderate Education Specialist Preliminary Credential and the Multiple Subject Teaching Credential at the same time.

The Master of Health Administration in the College of Health and Community Well-Being is available part- and full-time. Learning objectives in this program include an in-depth understanding of the complex facets of health services management; specialized skills on how to analyze issues and recognize trends in healthcare; and knowledge on how to integrate evolving trends in healthcare management, leadership, finance, human resources, and information technology. Students may select from several high-demand concentrations: financial management, public health, supply chain management, or health data analytics.

The Master of Public Administration in the College of Business and Public Management is also available part- and full-time. The nationally-ranked and accredited program develops public service professionals looking to engage in socially responsible roles in their communities and organizations, including in local, state, and national government. Degree specializations include urban management and affairs, nonprofit management and governance, and public health.

The University of La Verne now offers more than a dozen undergraduate and graduate programs fully online. Programs are taught by experienced faculty, class sizes are small to ensure that each student gets personal attention, and students are eligible to take advantage of the full range of services provided by the university. Some online programs include fieldwork components that must be completed in an in-person environment.

The University of La Verne’s online programs are available to students in select states.

For more information, visit laverne.edu/online.

About the University of La Verne

Founded in 1891, the University of La Verne is a private, nonprofit, comprehensive institution founded on four core values: lifelong learning, ethical reasoning, civic and community engagement, and diversity and inclusivity. Ranked among the best in the country for social mobility by US News & World Report, the university serves more than 6,000 students on the historic La Verne location as well as across eight regional campuses and online.

Share article on social media or email:

WPH Announces Release Date for the 10th Edition of its Popular Western Fertilizer Handbook


An expert team of contributors has updated the book’s content to address current challenges facing western agriculture.

“This latest edition continues to promote and emphasize the agronomically sound and environmentally safe uses of fertilizers.”

Western Plant Health (WPH) today announced that the release date for the 10th Edition of its immensely popular Western Fertilizer Handbook will be September 7, 2022 and is now available for pre-orders here.

For almost 70 years, agronomists throughout the western United States have relied on the Western Fertilizer Handbook for the most accurate information to maintain efficient and profitable growing programs, according to WPH. This latest edition continues to promote and emphasize the agronomically sound and environmentally safe uses of fertilizers.

“Ever since we created this this handbook in the 1950s, it has served as an indispensable resource for western farmers, agronomists, crop advisors and those in academia,” said Renee Pinel, President & CEO of WPH. “There are thousands of these books in circulation and there is a large audience eager to obtain this latest edition.”

An expert team of contributors has updated the book’s content to address current challenges facing western agriculture. Additional material has been added on micro-irrigation; soil, water, and tissue analysis; remote sensing of crop nutrient and water status; and agronomic decision support software.

The handbook is intended as a way to develop a better understanding of the different agronomic principles and practices as well as the different factors related to soil, water, plants, and fertilizers. It is used in universities across the West as part of their agricultural curriculum and serves as the primary study guide for candidates taking the California Certified Crop Adviser exam.

The handbook is a “practical tool for agronomists, CCAs, and PCAs working in the West, where it can frequently be found in their pickup trucks and offices because it is such a valuable resource,” said C. Scott Stoddard, a farm advisor and PCA with the University of California Cooperative Extension. ”Additionally, it is an excellent resource and textbook for classes on soil fertility and irrigation management.“

Click here to pre-order: Western Fertilizer Handbook

371 pages, $54.95 list

ISBN 10: 1-4786-4739-6

ISBN 13: 978-1-4786-4739-3

About Western Plant Health:

Western Plant Health (WPH) is a Sacramento-based trade association whose member companies promote the environmentally safe and agronomically sound use of their products. WPH members provide farmers with a wide range of crop protection and fertilizers necessary for safely growing crops that produce nutritious food and high-quality fiber, as well as horticultural products.

Share article on social media or email: